Does Warfarin or Rivaroxaban at Low Anticoagulation Intensity Provide a Survival Benefit to Asian Patients With Atrial Fibrillation?

por Lin, Dong, Chen, Yequn, Yong, Jian, Wu, Shiwan, Zhou, Yan, Li, Weiping, Tan, Xuerui, Liu, Ruisheng
Publicado 2021

Efficiency of atorvastatin on in-hospital mortality of patients with acute aortic dissection (AAD): study protocol for a randomized, open-label, superiority clinical trial

por Chen, Yequn, Xiong, Nianling, Wang, Xin, Wu, Shiwan, Hong, Liangli, Huang, Xiru, Chen, Chang, Li, Weiping, Wang, Bin, Ye, Shu, Tan, Xuerui
Publicado 2021

Predicting All-Cause Mortality Risk in Atrial Fibrillation Patients: A Novel LASSO-Cox Model Generated From a Prospective Dataset

por Chen, Yu, Wu, Shiwan, Ye, Jianfeng, Wu, Muli, Xiao, Zhongbo, Ni, Xiaobin, Wang, Bin, Chen, Chang, Chen, Yequn, Tan, Xuerui, Liu, Ruisheng
Publicado 2021

The association of coagulation indicators with in-hospital acute kidney injury and malignant events of patients with acute aortic dissection: a retrospective cohort study

por Jiang, Shiyan, Li, Yinhua, Li, Chenlin, Shu, Zhouwu, Wu, Shiwan, Lu, Xiaojia, Liu, Yue, Deng, Yinlong, Chen, Yequn, Cai, Peiwei, Wang, Bin
Publicado 2023

Dysnatremia is associated with increased risk of all-cause mortality within 365 days post-discharge in patients with atrial fibrillation without heart failure: A prospective cohort...

por Zhou, Yan, Lin, Dong, Wu, Shiwan, Xiao, Jiaxin, Yu, Min, Xiao, Zhongbo, Wu, Muli, Chen, Zhisheng, Tian, Cuihong, Chen, Rongbing, Chen, Yequn, Tan, Xuerui
Publicado 2022

Non-O blood group is associated with lower risk of in-hospital mortality in non-surgically managed patients with type A aortic dissection

por Huang, Song, Chen, Yequn, Huang, Zhaotao, Wu, Shiwan, Xiong, Nianling, Huang, Xiru, Wang, Xin, Chen, Chang, Wang, Bin, Li, Weiping, Hong, Liangli, Ye, Shu, Tan, Xuerui
Publicado 2020